ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 124,18
-0,09%
Dow Jones
39 056,39
0,44%
DAX
18 537,30
0,27%
Brent Oil
83,985
0,51%
Bitcoin
61 282,68
0,16%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Benitec Biopharma Limited (BNTC)

  7. Benitec Biopharma Limited (BNTC) Actualités

BNTC Benitec Biopharma Limited

8,64
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Benitec Biopharma Limited BNTC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 8,64 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
8,64
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/3/202422:17EDGAR2Form 8-K - Current report
08/3/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/2/202415:06EDGAR2Form DEL AM - Delaying amendment
23/2/202422:09EDGAR2Form S-3 - Registration statement under Securities Act of..
13/2/202414:15EDGAR2Form 8-K - Current report
13/2/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/12/202322:15EDGAR2Form 8-K - Current report
30/11/202313:31EDGAR2Form 8-K - Current report
17/11/202314:00GLOBEBenitec Biopharma to Participate in a Fireside Chat at the..
13/11/202314:03EDGAR2Form 8-K - Current report
13/11/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:00GLOBEBenitec Biopharma Releases First Quarter 2024 Financial..
20/10/202322:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/10/202312:04EDGAR2Form DEF 14A - Other definitive proxy statements
16/10/202323:29EDGAR2Form 8-K - Current report
28/9/202323:19EDGAR2Form 8-K - Current report
21/9/202314:05EDGAR2Form 8-K - Current report
21/9/202314:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/9/202314:00GLOBEBenitec Biopharma Releases Full Year 2023 Financial Results..
18/9/202323:26EDGAR2Form 8-K - Current report
14/8/202323:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:01EDGAR2Form 8-K - Current report
11/8/202319:00GLOBEBenitec Biopharma Inc. Announces Closing of $30 Million..
10/8/202322:42EDGAR2Form 8-K - Current report
10/8/202322:06EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
09/8/202304:30GLOBEBenitec Biopharma Inc. Announces Pricing of $30 Million..
07/8/202314:11EDGAR2Form S-1/A - General form for registration of securities..
03/8/202314:27EDGAR2Form S-1/A - General form for registration of securities..
31/7/202314:34EDGAR2Form S-1/A - General form for registration of securities..
25/7/202320:08EDGAR2Form 8-K - Current report
25/7/202319:00GLOBEBenitec Biopharma Announces 1-for-17 Reverse Stock Split..
07/7/202322:52EDGAR2Form S-1 - General form for registration of securities under..
26/6/202314:00GLOBEBenitec Biopharma Receives FDA Clearance of the IND for..
15/5/202314:00GLOBEBenitec Biopharma Releases Third Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
BNTC
Benitec Biopharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés